Neoplasms: all 9,610 studies

Page 85 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
• Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneCompletedNCT00993694
• Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous CancerCompletedNCT00993512Phase 1
• Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical DonorCompletedNCT00993486Phase 1/2
• Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative DisordersTerminatedNCT00992732Phase 2
• EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant NeoplasmsCompletedNCT00991614
• Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas TumoursSuspendedNCT00991601Not applicable
• A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)CompletedNCT00990912Phase 1/2
• Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
• High Dose Somatostatin Analogues in Neuroendocrine TumorsCompletedNCT00990535Phase 2
• Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous LesionsCompletedNCT00989443Phase 1
• Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous NeoplasmCompletedNCT00988416
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)CompletedNCT00986843Phase 1
• AT9283 in Children and Adolescents With Relapsed and Refractory Solid TumorsCompletedNCT00985868Phase 1
• Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaCompletedNCT00985777Phase 1
• The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid TumorsCompletedNCT00984425Phase 1
• Trial of Radiotherapy and Panitumumab in Salivary Gland MalignanciesWithdrawnNCT00984217Phase 2
• Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell TumorsStatus unknownNCT00983398Phase 1/2
• Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With CancerCompletedNCT00982566Phase 1
• A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid MalignanciesCompletedNCT00981721Phase 1
• RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant ObstructionCompletedNCT00980889Phase 4
• HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid MalignanciesCompletedNCT00979563Phase 1
• A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced MalignanciesCompletedNCT00978926
• Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid TumorsCompletedNCT00977210Phase 1
• A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic MalignanciesTerminatedNCT00977067Phase 1
• A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung CancerTerminatedNCT00975767Phase 1
• QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCompletedNCT00974896Phase 1
• Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055CompletedNCT00973076Phase 1
• Study of KRN951 in Patients With Solid TumorsCompletedNCT00970411Phase 1
• Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid TumorsCompletedNCT00968916Phase 1
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid MalignanciesCompletedNCT00968760Phase 1
• Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid TumorsTerminatedNCT00966498Not applicable
• Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantCompletedNCT00964821
• Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
• Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsCompletedNCT00962494Phase 2
• Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and PatientsCompletedNCT00961831Phase 1
• Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors.CompletedNCT00960258Phase 1
• STAT3 Inhibitor for Solid TumorsCompletedNCT00955812Phase 1
• Maintenance Study on the Long Term Safety of XL999CompletedNCT00955084Phase 1
• Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersTerminatedNCT00952185Not applicable
• A Standardized Nursing Intervention Protocol for HCT PatientsCompletedNCT00951626Not applicable
• Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, ChinaCompletedNCT00951262Phase 4
• A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid TumorsTerminatedNCT00951158Phase 1
• CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid TumorsCompletedNCT00949624Phase 1
• Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid TumorsCompletedNCT00949559Phase 1
• Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic StageCompletedNCT00949364Phase 2
• A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1CompletedNCT00948961Phase 1/2
• Study of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT00948467Phase 1
• ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
• Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
• Assessing the Effectiveness of Individual Education Plans for Childhood Cancer SurvivorsCompletedNCT00945828Not applicable
• Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent TumorsTerminatedNCT00944372Phase 4
• Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid TumorsCompletedNCT00942799Phase 1
• Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
• Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod TreatmentCompletedNCT00941811Phase 2
• Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- CetuximabCompletedNCT00941499Phase 1
• ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialCompletedNCT00941252Phase 2/3
• Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
• TTP607 in Refractory Solid MalignanciesWithdrawnNCT00939172Phase 1
• Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTerminatedNCT00937664Phase 1
• Open Versus Laparoscopically-assisted Esophagectomy for CancerCompletedNCT00937456Not applicable
• Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell TransplantationStatus unknownNCT00934557Phase 3
• SORAVE - Sorafenib and Everolimus in Solid TumorsCompletedNCT00933777Phase 1
• HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsCompletedNCT00931931Phase 1
• Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical DysplasiaCompletedNCT00931190
• Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
• RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedNCT00927966Phase 1
• Cancer Patients' Knowledge About FatigueStatus unknownNCT00927433Not applicable
• Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
• Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid TumorsCompletedNCT00925275Phase 1
• A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid TumorsWithdrawnNCT00923728Not applicable
• Pharmacokinetic Studies Participation SurveyCompletedNCT00923468
• A Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00921869Phase 1
• Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal CancerCompletedNCT00921661Phase 1
• Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid TumorCompletedNCT00921336Phase 1
• Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid TumorsCompletedNCT00920595Phase 1
• Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control ProgramCompletedNCT00920504Not applicable
• Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT00919750
• Evaluation of Isolated Roux-en-Y Reconstruction After PancreaticoduodenectomyStatus unknownNCT00915863Not applicable
• A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.CompletedNCT00915083Phase 1
• Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of TreatmentCompletedNCT00914914Phase 1
• Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to TreatmentCompletedNCT00909831Phase 1
• A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal AdenocarcinomasCompletedNCT00909402Phase 1
• Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmCompletedNCT00908869Phase 1
• A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid TumorsCompletedNCT00907205Phase 1
• Evaluation of [18F]-FMISO for Non Operated GlioblastomaCompletedNCT00906893Phase 2
• Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT00904787Phase 1
• LY2275796 in Advanced CancerCompletedNCT00903708Phase 1
• Study of Radiation Exposure and Bilateral Breast CancerActive, not recruitingNCT00903591
• rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant TumorsStatus unknownNCT00902083Phase 4
• Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate CancerCompletedNCT00900614Phase 1
• Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
• Collecting and Storing Blood Samples From Patients With CancerWithdrawnNCT00900120
• Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical CancerWithdrawnNCT00900081
• Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
• Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaCompletedNCT00900055
• DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem GliomaCompletedNCT00899834
• Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for CancerWithdrawnNCT00899808
• Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung CancerCompletedNCT00899782

← Neoplasms overview